Eris Lifesciences (ERIS) Share Price hits fresh 52-week low at Rs 1,163.95
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
Eris Lifesciences Share Price touched a fresh 52-week low of Rs 1,163.95 and was trading at Rs 1,167.70, down 1.88%, with market capitalisation at Rs 16,904.60 crore.
Eris Lifesciences Share Price moved to a fresh 52-week low in early trade, with Eris Lifesciences Ltd. (ERIS) last traded at Rs 1,167.70, down Rs 22.40 or 1.88% from the previous close of Rs 1,190.10. The stock’s intraday range also marked the one-year low, and the market capitalisation stood at Rs 16,904.60 crore. Univest data confirms the move itself, though no company-specific trigger has been identified. For readers tracking Eris Lifesciences Share Price today, the latest move places the stock in a fresh yearly low zone while keeping the discussion centered on verified price action, valuation and sector context.
In Eris Lifesciences Stock News, the key point is not just the low itself but the shape of the move: the stock opened at Rs 1,191.50, matched the day’s high at Rs 1,191.50, and then touched Rs 1,163.95 before being quoted slightly above that level. This is why Eris Lifesciences Share Price has drawn attention in Stock Market Today updates, especially among Stocks in News and Top Losers Today. According to latest Univest figures, the event is a fresh 52-week low, not an all-time low. The next sections place Eris Lifesciences Share Price in its fundamental and sector setting.
Eris Lifesciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,167.7 |
| Previous Close | Rs 1,190.1 |
| Today's Move | Rs -22.4 (-1.88%) |
| Open | Rs 1,191.5 |
| High | Rs 1,191.5 |
| Low | Rs 1,163.95 |
| Market Capitalisation | Rs 16,904.6 crore |
Eris Lifesciences Ltd. (ERIS) traded at Rs 1,167.7 versus the previous close of Rs 1,190.1, a fall of 1.88%. The stock opened at Rs 1,191.5, reached a high of Rs 1,191.5, touched a low of Rs 1,163.95.
Eris Lifesciences Share Price traded at Rs 1,167.70 against the previous close of Rs 1,190.10, reflecting a decline of Rs 22.40 or 1.88%. The day opened at Rs 1,191.50, touched a high of Rs 1,191.50 and a low of Rs 1,163.95, which is also the fresh 52-week low. Market capitalisation remained Rs 16,904.60 crore. As of 01 October 2026 at 9:22 AM IST, the price action shows the stock trading near the day’s low and within a narrow range after the open.
For Eris Lifesciences Share Price, the practical reading is straightforward: the stock set a fresh one-year low while still trading above that exact low point. The move places Eris Lifesciences Share Price Today among 52 Week Low Stocks in the current Indian Stock Market tone. Univest data confirms the move itself, though no company-specific trigger has been identified. That makes the next layer of analysis important: fundamentals, valuation and how Eris Lifesciences Share Price compares with its healthcare peers. Eris Lifesciences Share Price therefore needs to be read together with its ratios and business metrics rather than as a stand-alone move.
Eris Lifesciences Ltd. (ERIS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 16,904.6 crore |
| P/E Ratio | 25.64x |
| P/B Ratio | 4.09x |
| ROE | 19.23% |
| ROCE | 14.47% |
| EPS | Rs 46.41 |
| Book Value Per Share | Rs 290.65 |
| Dividend Yield | 0% |
Eris Lifesciences Ltd. (ERIS) fundamental metrics show P/E 25.64x, P/B 4.09x, ROE 19.23%, ROCE 14.47%. Read together, these ratios describe the company’s position rather than a recommendation.
Eris Lifesciences Ltd. has a market capitalisation of Rs 16,904.6 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.64x, P/B at 4.09x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.23% and ROCE of 14.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 46.41, book value per share of Rs 290.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.19x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 25.64x |
| Benchmark Median P/E | 32.19x |
| Benchmark Average P/E | 49.31x |
| Benchmark P/E Range | 3.4x to 688.17x |
| Company P/B Ratio | 4.09x |
| Benchmark Median P/B | 2.92x |
| Company ROE | 19.23% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 14.47% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 16,904.6 crore |
| Benchmark Median Market Cap | Rs 765.11 crore |
Eris Lifesciences Ltd. (ERIS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 25.64x, which is below the benchmark median of 32.19x, a difference of -20.35%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Eris Lifesciences Ltd. (ERIS) has a ROE of 19.23%, which is above the benchmark median of 11.7%, a difference of +64.36%. Eris Lifesciences Ltd. (ERIS) has a ROCE of 14.47%, which is above the benchmark median of 13.46%, a difference of +7.5%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Alembic Pharmaceuticals Ltd. | APLLTD | 16,905.41 | 23.42 | 2.78 | 12.35 | 11.74 |
| Glenmark Life Sciences Ltd. | ALIVUS | 16,931.41 | 28.08 | 4.86 | 18.41 | 24.61 |
| Jubilant Pharmova Ltd. | JUBLPHARMA | 16,719.74 | 46.54 | 2.3 | 5.97 | 8.69 |
| Suven Pharmaceuticals Ltd. | COHANCE | 17,475.13 | 159.98 | 4.42 | 4.02 | 6.12 |
| Pfizer Ltd. | PFIZER | 17,906.81 | 24.12 | 4.02 | 17.16 | 23.39 |
Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 25.64x compared with the displayed peer median of 28.08x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 19.23% compares with a peer median of 12.35% across the companies shown in the table. ROCE stood at 14.47% versus the displayed peer median of 11.74%, providing a capital-efficiency comparison. Eris Lifesciences Ltd. (ERIS) has a market capitalisation of Rs 16,904.6 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Eris Lifesciences
- Eris Lifesciences Share Price set a fresh 52-week low of Rs 1,163.95 while trading at Rs 1,167.70.
- The day move was Rs 22.40 lower, or 1.88%, versus the previous close.
- Eris Lifesciences Share Price has a P/E of 25.64 and ROE of 19.23%, which places it below and above different sector markers.
- The latest quarter revenue of Rs 873.25 crore for Jun 2026 gives context to the current Eris Lifesciences Share Price.
- Peer comparison shows Eris Lifesciences Share Price trading near several large healthcare names on market capitalisation.
About Eris Lifesciences
Eris Lifesciences Share Price belongs to Eris Lifesciences Ltd., a company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The business operates in branded pharmaceuticals, with revenue coming from its pharmaceutical portfolio. The latest quarter revenue of Rs 873.25 crore for Jun 2026 provides a current operational reference for Eris Lifesciences Share Price readers.
As a listed pharmaceutical company, Eris Lifesciences is assessed through the lens of earnings, book value and returns rather than only through price movement. Its EPS of Rs 46.41 and book value of Rs 290.65 help frame the company’s financial base, while ROE of 19.23% and ROCE of 14.47% show how the business is generating returns on equity and capital. For readers following Eris Lifesciences Share Price, this company overview matters because the stock is being tracked inside a healthcare industry where valuation and return measures vary widely. Eris Lifesciences Stock News therefore combines company-level metrics with the broader industry backdrop.
Track Eris Lifesciences Share Price on Univest
Use Eris Lifesciences Ltd. (ERIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Track Eris Lifesciences Share Price on Univest for live price updates, Eris Lifesciences Market Cap, Eris Lifesciences Fundamental Analysis, Eris Lifesciences Stock Analysis, 52-week levels, sector comparison and Eris Lifesciences Latest News. Univest also keeps Eris Lifesciences Share Price Today in context with valuation ratios, company financials and peer benchmarks so readers can follow Eris Lifesciences Share Price Live without guesswork.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Eris Lifesciences Share Price falling today?
Ans. Eris Lifesciences Share Price was down 1.88% at Rs 1,167.70 and touched a fresh 52-week low of Rs 1,163.95. Univest data confirms the move itself, though no company-specific trigger has been identified.
What is the fresh 52-week low for Eris Lifesciences Share Price?
Ans. The fresh 52-week low for Eris Lifesciences Share Price is Rs 1,163.95. The stock traded above that level at Rs 1,167.70 after opening at Rs 1,191.50 in the current session.
What is Eris Lifesciences Share Price today?
Ans. Eris Lifesciences Share Price was last traded at Rs 1,167.70, compared with the previous close of Rs 1,190.10. The day’s move was Rs 22.40 lower, or 1.88%, as of 01 October 2026 at 9:22 AM IST.
What is the market capitalisation of Eris Lifesciences Share Price?
Ans. Eris Lifesciences Share Price corresponds to a market capitalisation of Rs 16,904.60 crore. That places the company above the industry median market cap of Rs 765.11 crore in the same-industry benchmark set.
How does Eris Lifesciences Share Price compare on P/E ratio?
Ans. Eris Lifesciences Share Price is trading at a P/E ratio of 25.64, below the same-industry median of 32.19 and the average of 49.31. That places it in a relatively lower earnings multiple band versus the benchmark set.
How strong is Eris Lifesciences Share Price on return ratios?
Ans. Eris Lifesciences Share Price is supported by ROE of 19.23% and ROCE of 14.47%. Both are above the same-industry medians of 11.70% and 13.46%, which helps frame the stock’s fundamental profile.
What do the EPS and book value of Eris Lifesciences Share Price show?
Ans. Eris Lifesciences Share Price has EPS of Rs 46.41 and book value of Rs 290.65. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
Does Eris Lifesciences Share Price have a dividend yield?
Ans. Eris Lifesciences Share Price carries a dividend yield of 0. The stock’s current analysis therefore rests more on earnings, book value, return ratios and sector comparison than on payout income.
Should investors track Eris Lifesciences Share Price after the low?
Ans. Investors tracking Eris Lifesciences Share Price should monitor the next price update, company financials, sector comparison and the company’s position relative to peers. The fresh 52-week low makes valuation context and fundamental ratios especially relevant.
